Product Categories

INDUSTRY NEWS

 

 

Sanofi and Google partner to improve diabetes treatment........... 

Sanofi and Google will work together on new digital technology and tools for enhancing the management and treatment of diabetes;

Europe bans drugs tested by GVK; FDA monitors but keeps allowing sales........... 

The US FDA has found no systemic issues affecting the safety or efficacy of generics clinically tested at GVK BioSciences, but says it supports Europe’s ban of around 700 products;

‘Eat or be eaten;’ Mylan says Perrigo could be run as subsidiary........... 

Mylan will run Perrigo as a wholly-owned subsidiary if it acquires between 50-80% of shares, the firm has clarified;

Takeda invests in microdose tech collaborator Presage Biosciences........... 

Takeda has invested in Presage Biosciences whose tech platform is designed to let pharmas test multiple cancer drug combinations in a single trial;

Corbus gets FDA fast track status for Resunab to treat systemic sclerosis........... 

Corbus Pharmaceuticals Holdings has secured fast track status from the US Food and Drug Administration (FDA) for Resunab to treat systemic sclerosis (scleroderma), a serious, life-threatening autoimmune disease;

Concept Life Sciences buys UK toxicology biz........... 

British CRO Concept Life Sciences has bought toxicology business CXR Biosciences, its fourth acquisition since it formed in July 2014;

Charles River plans cautious approach to re-opening of Shrewsbury preclinical site........... 

After months of speculation , Charles River Laboratories has decided to move forward with the re-opening of its early-stage research site in Shrewsbury, Massachusetts sometime in the first quarter of 2016;

GSK plans to reopen contaminated NC site this weekend........... 

The GSK site tainted with Legionella bacteria will likely reopen in a few days, the company says;

Indian CRO hit with FDA warning letter over two specific violations........... 

Indian contract testing company Sipra Labs has received a warning letter from the US FDA over issues with the company's validation of test methods and failure to investigate out of specification test results;

GSK-Theravance's Breo Ellipta gets Canadian approval to treat asthma in adults........... 

GlaxoSmithKline (GSK) and Theravance have received approval in Canada for Breo Ellipta for the once-daily maintenance treatment of asthma in patients aged 18 years and older;

Lilly ends Alzheimer’s study contract with UCSD as California judge steps in........... 

Eli Lilly on Tuesdaycut ties with the University of California, San Diego (UCSD) as a legal battle between UCSD and the University of Southern California (USC) continues over the control of a major Alzheimer's disease study;

Ligand licenses Captisol to Sanofi for development of MET kinase inhibitor........... 

Ligand Pharmaceuticals (LGND) has licensed chemically modified cyclodextrin Captisol to Sanofi for use in the development and commercialization of SAR-125844;

Pediatric cancer treatment based on Nanosmart platform obtains FDA's orphan drug status............ 

 

EyeGate gets USPTO notice of allowance for proprietary dexamethasone phosphate formulation........... 

<a data-cke-saved-href="http://itsoftware.pharmaceutical-business-review.com/news/pediatric-cancer-treatment-based-on-nanosmart-platform-obtains-fdas-orphan-drug-status-310715-4636000=" href="http://itsoftware.pharmaceutical-business-review.com/news/pediatric-cancer-treatment-based-on-nanosmart-platform-obtains-fdas-orphan-drug-status-310715-4636000=" _blank"="">"Marksans Pharma Inc, the wholly owned subsidiary, acquired 100 percent of the outstanding shares of Time-Cap Laboratories Inc, a New York corporation," said the company in its filing.;

Supreme Court restrains Glenmark from producing anti-diabetes medicines........... 

In a relief to US pharma major Merck Sharp and Dohme, the Supreme Court today restrained Indian firm Glenmark Pharmaceuticals;

Bristol-Myers Squibb acquires exclusive license from Novo Nordisk for a discovery research program focused on autoimmune diseases............ 

Bristol-Myers Squibb Company (NYSE:BMY) today announced the company has signed an agreement with Novo Nordisk under which Bristol-Myers >

Aurobindo Pharma gets tentative nod from USFDA for Lacosamide tablets.............. 

Drug firm Aurobindo Pharma has received tentative approval from the US

Lupin ties up with Acceliant for clinical research........ . .............. 

Pharma major LupinBSE 1.73 % has tied up with Acceliant to use the Bangalore-based firm's platform in its drug research programmes

Four initiatives from across Africa win share of global US$1 million Healthcare Innovation Award ............ . .............. 

A simple mobile-phone app that helps staff at human milk banks (HMBs) with the pasteurisation of donor breast milk and a life-saving kit for the treatment of diarrhoea in under-fives have been awarded

Experts recommend weight loss drugs, surgery as supplement to lifestyle interventions

The Endocrine Society today issued a Clinical Practice Guideline (CPG) on strategies for prescribing drugs to manage obesity and promote weight loss.. ........................ 

Finance Ministry pitches for easing of FDI norms in pharma sector

NEW DELHI: Foreign direct investment in pharmaceutical sector is back in the spotlight.. ........................ 

USFDA vigilance on Chinese drug companies may benefit Indian counterparts

HYDERABAD: Indian drug makers see a significant business opportunity in the American regulator's decision to step up vigilance on Chinese companies that could lead to a dip in China's exports......................... 

Novo Nordisk second best in the world at providing access to medicine

Today, it was announced that Novo Nordisk ranks second on the 2014 Access to Medicine Index.. ........................ 

 

Mylan introduces generic Loestrin 24 Fe in US markets

Mylan Inc., a global pharmaceutical company, has launched norethindrone acetate and ethinyl estradiol tablets USP, 1 mg/0.02 mg and ferrous fumarate, a generic version of Warner Chilcott's Loestrin 24 Fe in US markets. .. ........................ 

AstraZeneca launches Healthy Heart Africa programme to address hypertension in Africa

AstraZeneca has launched a programme aimed at tackling the burden of hypertension in Africa.. ........................ 

The 2014 Nobel Prize in Physiology or Medicine

The Nobel Assembly at Karolinska Institutet has today decided to award The 2014 Nobel Prize in Physiology or. ............ . .............. 

Natco Pharma and Orchid Chemicals and Pharmaceuticals have received an adverse observation report - See more at: http://indianexpress.com/article/business/companies/natco-pharma-orchid-chemicals-get-a-strong-dose-of-us-fda-medicine/#sthash.ysdvpkKJ.dpuf ............ . .............. 

Scientists discover new, noncommittal mechanism of drug resistance

Current Openings

1. Role: Associate/ Sr. Associate - Business Development, Location : Mumbai, Qualifications :B Sc (Chem.) / B Pharm with MBA, Apply At :careers@vivanls.com  

2. Role: Project Coordinator, Location : Mumbai, Qualifications :B Sc (Chem.) / B Pharma, Apply At :careers@vivanls.com  

VIVAN Life Sciences is Knowledge driven innovative global enterprise, offering higher end products in Pharmaceuticals and Life Sciences.
We provide break through collaboration for the niche pharmaceutical products, which enhance the capability and productivity performances of our customers and Business Associates around the world, In specific functions critical to their success.

Drug Reference Standards | Working standards | Drug Impurities | Deuterium Labeled compounds-VIVAN

Online Product Assistant

  Search By - Product name Cas No Formula
About Us

Welcome to VIVAN Life Sciences

VIVAN Life Sciences is a Knowledge based and technology driven innovative Global Enterprise, offering higher end products in Pharmaceuticals and Life Sciences.

We provide break through collaboration for the niche pharmaceutical products, which enhance the capability and productivity performances of our customers and Business Associates around the world, In specific functions critical to their success.

Our Esteemed Clientele consists of, Global Pharmaceuticals and Life Sciences Companies, Pharmaceutical Generic companies, CROs (Contract Research Organizations), Clinical Research, Speciality Chemical Companies, Medical Research Organizations, world renowned Research Institutes and Universities.

We are instrumental in providing the higher-end products to our clientele around the world, and played an important role in the success of their Crucial projects.
there by improving and deriving exceptional value to the Projects critical to their success.

 

Please visit VIVAN BLOG:

  • To know the latest Industry News and Information.
  • Updates on technological evolutions in Pharma & Life Sciences.
  • Interesting story snippets for better contextual  understanding.
  • Short stories on Management & Leadership.

 

Last but not the least, We welcome your participation. This certainly helps us to better the content sharing on VIVAN BLOG

Loading...
Loading...
Loading...
Loading...
Loading...